SCHEMBL5801365

SCHEMBL5801365

CS(=O)(=O)Nc1ccc(C#N)cc1OC(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.50
HRH4 Q9H3N8 1/20 0.42
SLC22A12 Q96S37 6/20 0.41
BACE2 Q9Y5Z0 1/20 0.41
KIF11 P52732 1/20 0.40
PARP14 Q460N5 1/20 0.40
GCGR P47871 1/20 0.38
TRPV4 Q9HBA0 2/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
MLNR O43193 1/20 0.37
LMNA P02545 1/20 0.37
MMP1 P03956 1/20 0.37
MPO P05164 1/20 0.37
CYP1A2 P05177 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
MAPT P10636 1/20 0.37
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22819242 0.81 BACE2 (0.42) PGRHRH4BACE2GCGRTRPV4
SCHEMBL4650319 0.80 PSEN1 (0.46) PGRSLC22A12CYP3A4MAPT
SCHEMBL16887440 0.80 MRGPRX1 (0.47) PGRKIF11KDM4EMEN1MLNR
SCHEMBL4612598 0.79 PGR (0.81) PGR
SCHEMBL15220190 0.78 IDH1 (0.47) PGRHRH4SLC22A12KIF11CYP19A1
SCHEMBL4138666 0.78 GCGR (0.39) PGRHRH4SLC22A12BACE2GCGR
SCHEMBL16150577 0.78 BACE2 (0.42) PGRHRH4SLC22A12BACE2KIF11
SCHEMBL4398648 0.78 PDK1 (0.45) PGRHRH4BACE2GCGRCYP1A2
SCHEMBL10337745 0.78 PTGS1 (0.61) PGRSLC22A12PARP14KDM4EMEN1
SCHEMBL4650448 0.77 SLC22A12 (0.51) PGRSLC22A12TRPV4CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006098554-A1 NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-21 WO disclosed